POLY-HETEROARYL DERIVATIVES FOR THE TREATMENT OF CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110201648A1
SERIAL NO

13124136

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

of formulae I, II, III and IV respectively, the N-oxides, the pharmaceutically acceptable addition salts. The compounds claimed are suitable for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT CURIE26 RUE D'ULM PARIS CEDEX 05 75248
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)3 RUE MICHEL ANGE PARIS F-75016
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)101 RUE DE TOLBIAC PARIS 75013
MUSEUM NATIONAL D'HISTOIRE NATURELLE (MNHN)57 RUE CUVIER PARIS 75005

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Grierson, David Vancouver, CA 20 131
Guedin-Beaurepaire, Aurore Saint Michel sur orge, FR 1 0
Mergny, Jean-Louis Villejuif, FR 23 28
Monchaud, David Dijon, FR 2 0
Nguyen, Chi-hung Antony, FR 2 1
Riou, Jean-François Paris, FR 1 0
Rouchon, Dagois Myriam Palaiseau, FR 1 0
Teulade-Fichou, Marie-Paule Paris, FR 4 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation